European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
The European Society of Cardiology Annual Congress, held in Barcelona, included topics covering new therapeutic developments in the field of cardiovascular disease. This conference report highlights selected presentations on the development and progression of atherosclerosis, imaging techniques for treating atherosclerosis and clinical trials of treatments for cardiovascular disease. Investigational drugs discussed include ticagrelor (AstraZeneca AG).
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. karen.walker@thomsonreuters.com
Norman C W
NC
Wong
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000503:physiopathology; D002317:Cardiovascular Agents / Q000494:pharmacology*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D018450:Disease Progression; D016503:Drug Delivery Systems; D015195:Drug Design; D015507:Drugs, Investigational / Q000494:pharmacology; D006801:Humans
D002317:Cardiovascular Agents; D015507:Drugs, Investigational